NCT07594132 Randomized Trial of Next Generation Fluoroscopy System vs. Conventional Fluoroscopy System in Endoscopy
| NCT ID | NCT07594132 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Orlando Health, Inc. |
| Condition | Radiation Exposure |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2026-05 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2026-05 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fluoroscopy is an integral part of both basic and advanced gastrointestinal endoscopy procedures. Given the risks of radiation exposure and inherent limitations of preventive measures, there is a need for additional effective protective methods. In this randomized trial, we will be comparing radiation exposure between a next generation fluoroscopy system and conventional fluoroscopy system during fluoroscopy-guided endoscopic procedures.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Patients undergoing fluoroscopy-guided endoscopic procedure * Physicians and anesthesia staff participating in endoscopic procedures Exclusion Criteria: * Age \< 18 years * Pregnancy
Contact & Investigator
Ji Young Bang
PRINCIPAL INVESTIGATOR
Orlando Health
Frequently Asked Questions
Who can join the NCT07594132 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Radiation Exposure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07594132 currently recruiting?
Yes, NCT07594132 is actively recruiting participants. Contact the research team at jiyoung.bang@orlandohealth.com for enrollment information.
Where is the NCT07594132 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT07594132 clinical trial?
NCT07594132 is sponsored by Orlando Health, Inc.. The principal investigator is Ji Young Bang at Orlando Health. The trial plans to enroll 108 participants.